臨床試驗

Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer

NCT：NCT05889390 · ACTIVE_NOT_RECRUITING

NCT IDNCT05889390

狀態ACTIVE_NOT_RECRUITING

開始日期2023-02-20

完成時間2026-12-31

SponsorSemmelweis University (OTHER)

First posted2023-06-05

Last updated2026-05-15

簡要摘要

The aim of this study is to investigate whether the application of concomitant modulated electro-hyperthermia in a neoadjuvant chemotherapeutic setting is beneficial for patients with HER2-negative, stage II-III breast cancer.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。